Juliette Lemaignen will take over the management of the outpatient surgery center (CCA) on September 1, 2024. Created jointly by the Geneva University Hospitals (HUG) and Hirslanden, it will be operational at the end of 2025. It will be the largest outpatient surgery center in Switzerland.
Since 2015, Juliette Lemaignen, 45, has been a partner in the Inartis Foundation, a non-profit foundation whose main objective is to promote innovation and entrepreneurship in all technological fields, particularly in the life sciences. She is particularly responsible for managing incubators Station R et UniversityCity and develops projects at the interface between academic research and the industrial world. This role led her to work with the HUG on health data through a pediatric digital project in the field of liver transplantation.
Previously, she worked as a journalist since 2004 and, since 2009, she has held the position of editor-in-chief of the weekly “Biotech finances”, a publication specializing in financial and economic information on the European biopharmaceutical industry.
Unwavering support for innovation
As part of her innovation support activity, she participated in the creation and financing of the company Invivox, a training platform for health professionals, particularly surgeons. She held a place on the board of directors. She also worked as a consultant to enable the sales forces of pharmaceutical companies to understand the critical analysis of clinical trials and to integrate it into their current practice of promoting drugs to the medical profession.
Juliette Lemaignen holds an engineering degree in computer science and mathematics from the Université Paris-Panthéon-Assas – IMAC and a journalism degree from the Institut Français de Journalisme (IPJ). She also obtained an Executive Advanced Master in Strategy and Management of Health Industry from ESSEC Business School.
A unanimous decision
The CCA Board of Directors, composed of representatives of both institutions, unanimously decided to appoint Juliette Lemaignen as Director of the CCA. As of September 1, she will take responsibility for the center, which will come into service at the end of 2025. Stéphan Studer, Chairman of the CCA Board of Directors, explains: “I am very pleased that the management of the CCA is entrusted to a personality with a strong entrepreneurial and innovative spirit. I am convinced that the center will contribute significantly to the evolution towards outpatient surgery and will strengthen integrated care for the Geneva population.”
A unique outpatient surgery center in Switzerland
The result of a public-private partnership, this centre will be the largest of its kind in Switzerland. With a surface area of 4,000 m2, it will include ten operating theatres. Its capacity at the start of the activity is estimated at around 9,000 operations per year. It will be gradually increased according to needs and should reach 16,000 operations per year by 2040.
Contribute to reducing healthcare costs
The transfer of hospital operations to outpatient operations is one of the national priorities of the health sector for the coming years.
Through the “Outpatient before inpatient” program, the Confederation has put into effect at the beginning of 2023 a list containing 18 groups of interventions to be carried out on an outpatient basis (unless special circumstances require hospitalization) across Switzerland.
Shortening hospital care times to 12 hours, while ensuring the safety of care and medical monitoring, will help reduce the costs of the health system, which is a current first-level problem. It will also allow faster care for patients and greater comfort with a return home the same day.
Outpatient surgery offers the opportunity to improve the quality of certain specific treatments by developing dedicated innovative practices for them, which the Outpatient Surgery Center will focus on from its launch.
For more information, visit the website of Ambulatory surgery center.
